Cisatracurium Hikma

Cisatracurium Besilate is a neuromuscular blocking agent used for muscle relaxation during surgical procedures. Manufactured by Hikma, it is administered intravenously for short-term paralysis.

Cisatracurium Besilate is primarily used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. It is often employed in procedures requiring controlled ventilation. This medication is not used for long-term muscle relaxation but is crucial in surgical settings where muscle relaxation is necessary.

Cisatracurium Besilate works by blocking neuromuscular transmission, leading to temporary muscle paralysis. This effect allows surgeons to perform procedures with minimal interference from muscle movements. The onset of action is typically rapid, and the duration of effect is relatively short, making it suitable for short surgical interventions.

Cisatracurium Besilate should be administered by healthcare professionals experienced in the use of neuromuscular blocking agents. It is essential to monitor the patient's respiratory status closely during and after administration. Patients with certain medical conditions, such as severe liver or kidney disease, may require special consideration.

Cisatracurium Besilate may interact with other medications that affect neuromuscular transmission, such as certain anesthetics and antibiotics. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other sedatives should be avoided as they can enhance the effects of Cisatracurium Besilate.